[go: up one dir, main page]

SE7707992L - Forfarande for framstellning av en blodkoagulationsbefremjande preparation av humanblodplasma - Google Patents

Forfarande for framstellning av en blodkoagulationsbefremjande preparation av humanblodplasma

Info

Publication number
SE7707992L
SE7707992L SE7707992A SE7707992A SE7707992L SE 7707992 L SE7707992 L SE 7707992L SE 7707992 A SE7707992 A SE 7707992A SE 7707992 A SE7707992 A SE 7707992A SE 7707992 L SE7707992 L SE 7707992L
Authority
SE
Sweden
Prior art keywords
feiba
coagulation
blood
preparing
procedure
Prior art date
Application number
SE7707992A
Other languages
English (en)
Other versions
SE443511B (sv
Inventor
J Eibl
O Schwarz
F Elsinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of SE7707992L publication Critical patent/SE7707992L/sv
Publication of SE443511B publication Critical patent/SE443511B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
SE7707992A 1976-08-30 1977-07-08 Forfarande for framstellning av ett blodkoaguleringsbefremjande preparat ur humanblodplasma SE443511B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (2)

Publication Number Publication Date
SE7707992L true SE7707992L (sv) 1978-03-01
SE443511B SE443511B (sv) 1986-03-03

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7707992A SE443511B (sv) 1976-08-30 1977-07-08 Forfarande for framstellning av ett blodkoaguleringsbefremjande preparat ur humanblodplasma

Country Status (17)

Country Link
US (1) US4160025A (sv)
AR (1) AR213861A1 (sv)
AT (1) AT350726B (sv)
BE (1) BE858031A (sv)
CA (1) CA1079191A (sv)
CH (1) CH635747A5 (sv)
DE (1) DE2734821C3 (sv)
DK (1) DK151932C (sv)
ES (1) ES461918A1 (sv)
FI (1) FI57421C (sv)
FR (1) FR2362633A1 (sv)
GB (1) GB1554051A (sv)
HU (1) HU180816B (sv)
LU (1) LU78024A1 (sv)
NL (1) NL170922C (sv)
NO (1) NO148142C (sv)
SE (1) SE443511B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
DE3165600D1 (en) * 1980-01-28 1984-09-27 Baxter Travenol Lab Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
EP0041174B1 (en) * 1980-05-27 1985-09-11 Miles Laboratories, Inc. Blood coagulation promoting product and process of preparing same
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US5118614A (en) * 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
HUP9700603A3 (en) * 1996-03-20 2001-08-28 Baxter Ag Pharmaceutical preparation for the treatment of blood coagulation disorders
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
RS20050051A (en) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity
DE50311422D1 (de) * 2002-07-23 2009-05-28 Bio & Bio Licensing Sa Thrombingenerierfähige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
EP2305289A1 (en) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medicinal products for the treatment of blood coagulation disorders
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
JP2022041059A (ja) * 2020-08-31 2022-03-11 シスメックス株式会社 検量線の表示方法および分析装置
WO2024012853A1 (de) 2022-07-12 2024-01-18 Biomedizinische Forschung & Bio-Produkte AG Arzneimittel zur förderung der hämostase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (sv) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Also Published As

Publication number Publication date
FI57421C (fi) 1980-08-11
CH635747A5 (de) 1983-04-29
FI772408A (fi) 1978-03-01
FI57421B (fi) 1980-04-30
ES461918A1 (es) 1978-12-16
HU180816B (en) 1983-04-29
ATA640576A (de) 1978-11-15
NL170922C (nl) 1983-01-17
GB1554051A (en) 1979-10-17
SE443511B (sv) 1986-03-03
LU78024A1 (sv) 1978-01-11
NL7708872A (nl) 1978-03-02
DE2734821A1 (de) 1978-03-02
FR2362633A1 (fr) 1978-03-24
DK151932B (da) 1988-01-18
CA1079191A (en) 1980-06-10
NO772978L (no) 1978-03-01
AR213861A1 (es) 1979-03-30
DK384577A (da) 1978-03-01
US4160025A (en) 1979-07-03
BE858031A (fr) 1977-12-16
NO148142B (no) 1983-05-09
DE2734821B2 (de) 1980-11-06
DK151932C (da) 1988-06-20
NO148142C (no) 1983-08-17
DE2734821C3 (de) 1985-03-14
FR2362633B1 (sv) 1981-06-12
NL170922B (nl) 1982-08-16
AT350726B (de) 1979-06-11

Similar Documents

Publication Publication Date Title
SE7707992L (sv) Forfarande for framstellning av en blodkoagulationsbefremjande preparation av humanblodplasma
DE3461886D1 (en) Process for preparing a whey product
NO161674C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater.
EP0053338A3 (en) Process for the preparation of blood coagulation factors, and preparation containing factors ix and x
ZA754725B (en) Preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use
ZA829315B (en) Process for the preparation of a tissue thrombo-plastin
DE2960213D1 (en) Process for the preparation of saturated aliphatic, cycloaliphatic and araliphatic aldehydes
NO164276C (no) Fremgangsmaate for fremstilling av holdbare kamilleekstrakter.
DE69004425D1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
ES502084A0 (es) Procedimiento para tratar fracciones individuales de plasma sanguineo.
JPS5234840A (en) Sanitary interior fitting for shoes and production method of same
JPS5328509A (en) Treating method for increasing high temperature strength of pure titanium material
GB2001757A (en) Stabilised blood platelet suspension
PT71195A (en) Medicinal preparation for treating carcinomas and process of producing the preparation
ES2111068T3 (es) Proteina anti-vih, tap 29, a partir de trichosanthes codificada adn y usos terapeuticos de la misma.
GB1525815A (en) Texturization of protein
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
JPS5391188A (en) Preparation of glycyl lysine
JPS5219340A (en) Heat treatment system
JPS5239573A (en) Process for destroying the texture of the animal fibrous material by s welling and softening
JPS5265341A (en) Heat radiation body
JPS5355984A (en) Ion beam irradiating method and its device
JPS533534A (en) Local anesthetics
Aushri et al. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7707992-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7707992-9

Format of ref document f/p: F